GJA1 and lymphedema: Missense mutations in Cx43 (GJA1) and Cx47 (GJC2) are each linked to the development of lymphedema in humans (19–21), and women with mutations in GJC2 have an increased likelihood of developing lymphedema after breast cancer surgery (22).